Business Context and Reporting Period
This Form 6-K filing by Immuron Ltd, a foreign private issuer, covers the month of April 2019. The report was filed on April 17, 2019, to disclose a corporate announcement made to the Australian Securities Exchange regarding a change in the company's leadership structure.
Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report is a disclosure of a corporate event rather than a financial statement.
Material Changes
The primary material change disclosed is the appointment of Dr. Gary S. Jacob to the Board of Directors. Dr. Jacob is identified in the announcement as the Company's CEO.
Guidance, Outlook, and Risks
The filing contains no management commentary, financial guidance, outlook, or discussion of risks and contingencies. The document serves solely to transmit the attached public notice regarding the board appointment.
Key Facts for Investor Verification
- Dr. Gary S. Jacob has been appointed to the Board of Directors.
- Dr. Jacob currently holds the position of CEO.
- The announcement was originally published to the Australian Securities Exchange on April 17, 2019.
- No financial performance data is included in this specific filing.